中国中医科学院广安门医院
纸质出版:2021
移动端阅览
张孝刚, 胡帅航, 田培裕, 等. 朴炳奎治疗肿瘤常用药组探析[J]. 中医杂志, 2021,62(16):1395-1399.
ZHANG Xiaogang, HU Shuaihang, TIAN Peiyu, et al. Analysis of Professor PIAO Bingkui′s Commonly Used Drug Groups in Treating Tumors[J]. Journal of Traditional Chinese Medicine2021, 62(16): 1395-1399.
张孝刚, 胡帅航, 田培裕, 等. 朴炳奎治疗肿瘤常用药组探析[J]. 中医杂志, 2021,62(16):1395-1399. DOI: 10.13288/j.11-2166/r.2021.16.004.
ZHANG Xiaogang, HU Shuaihang, TIAN Peiyu, et al. Analysis of Professor PIAO Bingkui′s Commonly Used Drug Groups in Treating Tumors[J]. Journal of Traditional Chinese Medicine2021, 62(16): 1395-1399. DOI: 10.13288/j.11-2166/r.2021.16.004.
总结朴炳奎教授治疗肿瘤的常用药组
探讨其临证思路及学术观点。认为肿瘤核心病机为虚实两端
正气虚是肿瘤发病基础
临证强调扶正培本在肿瘤中医治疗中的核心地位
从而形成黄芪、当归、女贞子、枸杞子扶正培本药组
陈皮、炒山楂、炒神曲、炒麦芽护胃运脾药组;并充分考虑肿瘤特性及各脏腑生理特点
针对不同部位的肿瘤亦形成药组
如沙参、桔梗、麦冬、苦杏仁为治疗肺癌药组
急性子、白花蛇舌草、土茯苓、莪术为治疗食管癌药组
白术、山药、枳壳、益智仁为治疗胃癌、结直肠癌药组
北柴胡、白芍、枳壳、甘草为治疗卵巢癌、乳腺癌药组
威灵仙、续断、牛膝、骨碎补治疗骨肿瘤药组
天冬、赤芍、玄参、北沙参为治疗鼻咽癌药组。
This paper summarized professor PIAO Bingkui′s commonly used drug groups in treating tumors
and discussed his thoughts in clinical practice and academic researches. It is believed that the core disease mechanism of tumor should be considered as two aspects
deficiency and excess
and healthy qi deficiency is the basis of tumor pathogenesis. Therefore
reinforcing healthy qi and fostering the root is considered as the core treatment principle in clinical practice
and correspondingly drug groups are formulated including Huangqi(Radix Astragali)
Danggui(Radix Angelicae Sinensis)
Nuzhenzi(Fructus Ligustri Lucidi)
Gouqizi(Fructus Lycii) to reinforce healthy qi and foster root
as well as Chenpi(Pericarpium Citri Reticulatae)
Chaoshanzha(fried Fructus Crataegi)
Chaoshenqu(fried Massa Medicata Fermentata)
and Chaomaiya(dried Fructus Hordei Germinatus) to protect stomach and activate spleen. Simultaneously
the drug groups target to tumors in different parts can be developed after fully considering the tumor specifics and the physiological characteristics of related zang-fu organs(脏腑)
such as the drug group of Shashen(Radix Adenophorae seu Glehniae)
Jiegeng(Radix Platycodonis)
Maidong(Radix Ophiopogonis) and Kuxinren(Semen Armeniacae Amarum) for lung cancer; the group of Jixingzi(Semen Impatientis)
Baihua Sheshe Cao(Herba Hedyotis Diffusae)
Tufuling(Rhizoma Smilacis Glabrae) and Ezhu(Rhizoma Curcumae) for esophageal cancer; the group of Baizhu(Rhizoma Atractylodis Macrocephalae)
Shanyao(Rhizoma Dioscoreae)
Zhiqiao(Fructus Aurantii) and Yizhiren(Fructus Alpiniae Oxyphyllae) for stomach cancer and colorectal cancer; the drug group of Beichaihu(Bupleurum chinense DC.)
Baishao(Radix Paeoniae Alba)
Zhiqiao and Gancao(Radix et Rhizoma Glycyrrhizae) for ovarian cancer and breast cancer; the drug group of Weilingxian(Radix et Rhizoma Clematidis)
Xuduan(Radix Dipsaci)
Niuxi(Radix Achyranthis Bidentatae) and Gusuibu(Rhizoma Drynariae) for bone tumor; and the group of Tiandong(Radix Asparagi)
Chaishao(Radix Paeoniae Rubra)
Xuanshen(Radix Scrophulariae) and Beishashen(Radix Glehniae) for nasopharyngeal carcinoma.
0
浏览量
140
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号